Evaluation of Nafamostat as Chemoprophylaxis for SARS-CoV-2 Infection in Hamsters. (2023)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/v15081744
PubMed Identifier: 37632086
Publication URI: http://europepmc.org/abstract/MED/37632086
Type: Journal Article/Review
Volume: 15
Parent Publication: Viruses
Issue: 8
ISSN: 1999-4915